Dr. John P. Docherty

• 
  investor.lilly.com/releasedetail.cfm?releaseid=304993 - [Cached Version]
  Published on: 4/16/2008    Last Visited: 12/18/2008  

  Armed with the right information, physicians can make better treatment decisions," said John Docherty, M.D., founder and chairman at Comprehensive NeuroScience, Inc.

• 
  www.cmellc.com/catalog/d07433.html - [Cached Version]
  Published on: 11/22/2007    Last Visited: 11/22/2007  

  John Docherty, MDAdjunct Professor of Psychiatry, Cornell

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 4/16/2008    Last Visited: 4/16/2008  

  decisions," said John Docherty, M.D., founder and chairman at Comprehensive NeuroScience, Inc.

• 
  www.urac.org/bestpractices/session.asp?#Wednesday5 - [Cached Version]
  Published on: 3/26/2008    Last Visited: 7/2/2009  

  John P. Docherty, MD, President and CEO,Comprehensive NeuroScience, Inc.

• 
  www.cmepodcasting.com/cmea.asp?ID=214 - [Cached Version]
  Published on: 10/11/2006    Last Visited: 10/9/2007  

  John P. Docherty, MDAdjunct Professor of PsychiatryJoan and Sanford I. Weill Medical College

• 
  www.cmellc.com/events.html - [Cached Version]
  Published on: 9/5/2006    Last Visited: 3/17/2008  

  Join distinguished faculty Donald C. Goff, MD (Harvard), and John P. Docherty, MD (Cornell), as they explore medical and psychiatric comorbidities in patients, the pharmacokinetic properties of atypical antipsychotics, and tackle the challenges of polypharmacy.

• 
  www.urac.org/bestpractices/session.asp?#Wednesday1 - [Cached Version]
  Published on: 3/26/2008    Last Visited: 10/12/2008  

  John P. Docherty, MD, President and CEO

• 
  www.neuroscienceCME.com/CME.asp?faculty=72 - [Cached Version]
  Published on: 4/14/2007    Last Visited: 4/14/2007  

  John P. Docherty, MDneuroscienceCME - CME/CE Activities
  ...
  John P. Docherty, MD

• 
  www.facialmagic.com/He_Tips.htm - [Cached Version]
  Published on: 2/28/2005    Last Visited: 6/28/2006  

  The good news for these people is that John P. Docherty, MD, CEO of Comprehensive NeuroScience Inc., and adjunct professor of psychiatry at Weill Medical College, Cornell University in New York City, headed a recent study that looked at the role of chromium salts in helping to control blood sugar, and in turn, cravings.I spoke with Dr. Docherty who says that the carbohydrates that patients overindulge in the most are not surprising -- baked goods and pasta, both ranking high as comfort foods.But the resulting weight gain adds to patients' depression, and can be a sort of double-whammy since a common side effect of selective serotonin reuptake inhibitors (SSRIs) -- antidepressant medications, such as fluoxetine (Prozac) and sertraline (Zoloft) -- is weight gain, as well.
  
  The 113 participants in the eight-week study, all people with atypical depression and a mean body mass index (BMI) that was borderline obese, were randomized into a group taking up to 600 mg of chromium picolinate a day or a placebo group.The findings showed that the chromium picolinate group had a significant improvement -- 65% versus 33% in the placebo group -- in terms of decreased appetite and lowered carbohydrate craving.
  
  Dr. Docherty says we don't know exactly why chromium picolinate works to decrease carb cravings, but it probably has to do with the fact that it seems to enhance insulin regulation. (Many people with diabetes type 2 take it for this reason.) Daily Health News contributing editor Andrew L. Rubman, ND, however, adds that chromium seems to increase the sensitivity of chromium receptors, which in turn increases its effect on insulin regulation.

• 
  www.neuroscienceCME.com/CME_faculty.asp - [Cached Version]
  Published on: 4/14/2007    Last Visited: 4/14/2007  

  John P. Docherty, MD

Page:  1 2 3 4 5